The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Carlsson, A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Carlsson, A.

Am J Psychiatry 1978; 135:165-173
Copyright © 1978 by American Psychiatric Association


REGULAR ARTICLES

Antipsychotic drugs, neurotransmitters, and schizophrenia

A Carlsson

Inhibition of central dopamine functions appears to be a common basic property of antipsychotic drugs. The mesolimbic and nigrostriatal portions of the dopaminergic system are probably the main targets for the mental and the extrapyramidal actions, respectively, of these drugs. The fact that dopaminergic hyperfunction induced by amphetamines or dopa may lead to a disturbance mimicking paranoid schizophrenia lends further support for a key role of dopamine in mental functions. Although a primary disturbance in dopamine function in schizophrenia cannot be ruled out, the intimate relationship between dopaminergic and other neuronal systems must be emphasized. The possible involvement of other amine, amino acid, or peptide transmitters in schizophrenia cannot be disregarded.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. C. Horner, Y. Cazals, R. Guieu, M. Lenoir, and N. Sauze
Experimental estrogen-induced hyperprolactinemia results in bone-related hearing loss in the guinea pig
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1224 - E1232.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Freedman
Schizophrenia
N. Engl. J. Med., October 30, 2003; 349(18): 1738 - 1749.
[Full Text] [PDF]


Home page
J. Immunol.Home page
T. Borda, R. Perez Rivera, L. Joensen, R. M. Gomez, and L. Sterin-Borda
Antibodies Against Cerebral M1 Cholinergic Muscarinic Receptor from Schizophrenic Patients: Molecular Interaction
J. Immunol., April 1, 2002; 168(7): 3667 - 3674.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. Talvik, A.-L. Nordstrom, S. Nyberg, H. Olsson, C. Halldin, and L. Farde
No Support for Regional Selectivity in Clozapine-Treated Patients: A PET Study With [11C]Raclopride and [11C]FLB 457
Am J Psychiatry, June 1, 2001; 158(6): 926 - 930.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1978 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org